Is Cencora Stock Outperforming the S&P 500?
Due to Cencora's outperformance relative to the broader S&P 500 Index, Wall Street analysts remain strongly optimistic about the stock’s outlook.
Barchart ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
INSANE: International healthcare solutions - The Real Truth
Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook
Cencora, Inc. (NYSE:COR) on Wednesday reported third-quarter 2025 sales increased 8.7% to $80.66 billion, beating the consensus of $80.354 billion.
Benzinga ·
AmerisourceBergen Lifts FY22 Guidance As Q2 Earnings Beats Estimates
AmerisourceBergen Corp's (NYSE:ABC) Q2 FY22 adjusted EPS reached $3.22, up 27.3% Y/Y, beating the consensus of $2.93. Revenue of $57.7 billion increased by 17.4% Y/Y, beating the analyst consensus of $57.27 billion, reflecting a 585.3% increase in revenue within International Healthcare Solutions, primarily driven by the June 2021 acquisition of Alliance Healthcare…
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Benzinga
Barchart
Organisations
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
